NCT07366684

Brief Summary

This study will evaluate clinical characteristics, frailty, and predictors of prognosis in patients aged 75 years and older who are hospitalized with acute coronary syndrome (ACS). The research includes both a retrospective and a prospective cohort. The aim is to determine whether frailty scores, combined with clinical and laboratory parameters available at admission, can improve risk prediction for complications and mortality compared with standard risk scores (TIMI, GRACE, Syntax). The study will also compare outcomes between patients treated with percutaneous coronary intervention (PCI) and those treated conservatively with medications. Patients will be followed during hospitalization and for six months after discharge. The results are expected to contribute to more personalized treatment strategies for elderly patients with ACS.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for all trials

Timeline
13mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Mar 2026Jun 2027

First Submitted

Initial submission to the registry

December 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

December 1, 2025

Last Update Submit

January 16, 2026

Conditions

Keywords

Acute Coronary Syndrome (ACS)ElderlyFrailtyPercutaneous Coronary Intervention (PCI)Conservative TreatmentMajor adverse cardiovascular events (MACE)Prognostic Predictors / Risk Stratification

Outcome Measures

Primary Outcomes (1)

  • Impact of treatment strategy (PCI vs conservative therapy) on on all-cause mortality and major adverse cardiovascular events (MACE: cardiovascular death, myocardial infarction, stroke) in elderly patients with acute coronary syndrome (ACS)

    To compare outcomes of patients aged ≥75 years with ACS (STEMI, NSTEMI, unstable angina) treated with percutaneous coronary intervention (PCI) versus conservative medical therapy. The primary outcome includes all-cause mortality and major adverse cardiovascular events (MACE). Unit of Measure: % of patients experiencing event.

    Peri-procedurally (within 48 hours of PCI or index admission for conservative therapy), at discharge (assessed up to 14 days after admission (Day 1)), and at 6 months after discharge (± 14 days).

Secondary Outcomes (28)

  • Impact of treatment strategy (PCI vs conservative therapy) on hemorrhagic complications

    Peri-procedurally (within 48 hours of PCI or index admission) and at discharge (assessed up to 14 days after admission (Day 1)).

  • Number of Participants with ≥1 All-cause Rehospitalization

    6 months after discharge (± 14 days).

  • Demographic predictors of conservative management

    Baseline (Day 1).

  • Admission hemoglobin as predictor of conservative management

    Baseline.

  • Admission eGFR (CKD-EPI) as predictor of conservative management

    Baseline.

  • +23 more secondary outcomes

Study Arms (1)

Hospitalized Patients ≥75 Years With Acute Coronary Syndrome

Patients aged 75 years and older admitted with acute coronary syndrome (STEMI, NSTEMI, or unstable angina). Data will be collected retrospectively and prospectively, including clinical, laboratory, echocardiographic, angiographic, and frailty parameters. Outcomes will be assessed during hospitalization and at 6 months after discharge.

Procedure: Percutaneous Coronary Intervention (PCI)Other: Conservative Medical Therapy

Interventions

Patients receiving PCI as part of routine clinical care

Hospitalized Patients ≥75 Years With Acute Coronary Syndrome

Patients treated conservatively with guideline-directed medical therapy as part of routine care

Hospitalized Patients ≥75 Years With Acute Coronary Syndrome

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients aged 75 years and older with acute coronary syndrome (STEMI, NSTEMI, unstable angina) treated at the University Clinical Center Niš. Approximately 350 retrospective and 200 prospective patients are expected to be included.

You may qualify if:

  • Age ≥ 75 years
  • Diagnosis of acute coronary syndrome (STEMI, NSTEMI, or unstable angina)
  • Hospitalization in a tertiary care center (University Clinical Center Niš)
  • For prospective cohort: signed informed consent

You may not qualify if:

  • Refusal to provide informed consent (prospective cohort)
  • Missing or incomplete medical documentation (retrospective cohort)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Center Niš

Niš, 18000, Serbia

Location

Related Publications (7)

  • Narendren A, Whitehead N, Burrell LM, Yudi MB, Yeoh J, Jones N, Weinberg L, Miles LF, Lim HS, Clark DJ, Al-Fiadh A, Farouque O, Koshy AN. Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. J Clin Med. 2024 Jul 28;13(15):4416. doi: 10.3390/jcm13154416.

    PMID: 39124683BACKGROUND
  • Morici N, De Servi S, De Luca L, Crimi G, Montalto C, De Rosa R, De Luca G, Rubboli A, Valgimigli M, Savonitto S. Management of acute coronary syndromes in older adults. Eur Heart J. 2022 Apr 19;43(16):1542-1553. doi: 10.1093/eurheartj/ehab391.

    PMID: 34347065BACKGROUND
  • H Ratcovich, P Palm, J Faerch, L Bang, T Engstroem, H H Tilsted, L Holmvang, Prevalence and prognosis of frailty in patients >70 years old with acute coronary syndrome referred to invasive angiography. Eur Heart J Acute Cardiovasc Care. 2023;12(Suppl 1):zuad036.045. doi:10.1093/ehjacc/zuad036.045

    BACKGROUND
  • Szummer K, Montez-Rath ME, Alfredsson J, Erlinge D, Lindahl B, Hofmann R, Ravn-Fischer A, Svensson P, Jernberg T. Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome: Insights From the SWEDEHEART Registry. Circulation. 2020 Nov 3;142(18):1700-1708. doi: 10.1161/CIRCULATIONAHA.120.050645. Epub 2020 Sep 1.

    PMID: 32867508BACKGROUND
  • Aranzulla TC, Radano I, Civera S, Musumeci G. Acute coronary syndrome in elderly and frail patients. European Society of Cardiology - Council for Cardiology Practice, CardioPractice. Published August 6, 2024. Available at: https://www.escardio.org/Councils/Council-for-Cardiology-Practice-%28CCP%29/Cardiopractice/acute-coronary-syndrome-in-elderly-and-frail-patients

    BACKGROUND
  • Damluji AA, Forman DE, Wang TY, Chikwe J, Kunadian V, Rich MW, Young BA, Page RL 2nd, DeVon HA, Alexander KP; American Heart Association Cardiovascular Disease in Older Populations Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; and Council on Lifestyle and Cardiometabolic Health. Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association. Circulation. 2023 Jan 17;147(3):e32-e62. doi: 10.1161/CIR.0000000000001112. Epub 2022 Dec 12.

    PMID: 36503287BACKGROUND
  • Rout A, Moumneh MB, Kalra K, Singh S, Garg A, Kunadian V, Biscaglia S, Alkhouli MA, Rymer JA, Batchelor WB, Nanna MG, Damluji AA. Invasive Versus Conservative Strategy in Older Adults >/=75 Years of Age With Non-ST-segment-Elevation Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2024 Nov 5;13(21):e036151. doi: 10.1161/JAHA.124.036151. Epub 2024 Nov 4.

    PMID: 39494560BACKGROUND

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionMyocardial InfarctionNon-ST Elevated Myocardial InfarctionAngina, UnstableAcute Coronary SyndromeFrailty

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisAngina PectorisChest PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Central Study Contacts

Svetlana Apostolović

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Internal Medicine, Head of the Department of Internal Medicine, Faculty of Medicine, University of Niš; Cardiologist at the Institute for Cardiology, Clinical Center Niš

Study Record Dates

First Submitted

December 1, 2025

First Posted

January 26, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD), including demographics, clinical, laboratory, echocardiographic, angiographic, frailty scores, and outcomes, will be made available. A data dictionary will also be provided. Data will be shared with qualified researchers upon reasonable request, after publication of the main results, for up to 5 years. Access will require approval by the principal investigator and a signed data use agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
IPD and supporting documents will be available after publication of the main results and will remain accessible for 5 years.
Access Criteria
Access will be granted to qualified researchers affiliated with academic or healthcare institutions for non-commercial scientific purposes. Requests must include a research proposal and data use agreement.

Locations